Longeveron (LGVN) Other Non Operating Income (2020 - 2026)
Longeveron's (LGVN) quarterly Other Non Operating Income came in at $39000.0 in Q1 2026, down 77.06% year-on-year from $170000.0 in Q1 2025, and down 25.0% quarter-over-quarter from $52000.0 in Q4 2025.
Longeveron (LGVN) Other Non Operating Income (2020 - 2026) Analysis & Trends
Longeveron's Other Non Operating Income history runs 7 years deep, the most recent figure standing at $39000.0 for Q1 2026.
- On a quarterly basis, Other Non Operating Income fell 77.06% year-over-year to $39000.0 in Q1 2026; TTM through Mar 2026 was $549000.0, a 20.09% decrease from a year earlier, with the FY2025 full-year figure at $680000.0, up 23.86% from the prior year.
- Other Non Operating Income declined to $39000.0 in Q1 2026 per LGVN's latest filing, from $52000.0 in the prior quarter.
- Across five years, Other Non Operating Income topped out at $1.9 million in Q4 2022 and bottomed at -$1.4 million in Q2 2022.
- The 5-year median for Other Non Operating Income is $69000.0 (2023), against an average of $70058.8.
- Biggest YoY gain for Other Non Operating Income was 5170.27% in 2022; the steepest drop was 2798.08% in 2022.
- Year by year, Other Non Operating Income stood at $1.9 million in 2022, then plunged by 130.97% to -$581000.0 in 2023, then surged by 134.42% to $200000.0 in 2024, then plunged by 74.0% to $52000.0 in 2025, then decreased by 25.0% to $39000.0 in 2026.
- Per Business Quant, the three latest LGVN Other Non Operating Income figures stand at $39000.0 (Q1 2026), $52000.0 (Q4 2025), and $89000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,921.77 Bn | 66,921.49 Bn | - |
| 2 | Nanobiotix | 1,924.26 Bn | 1,924.20 Bn | - |
| 3 | Akari Therapeutics | 975.59 Bn | 975.59 Bn | - |
| 4 | BeOne Medicines | 471.47 Bn | 466.67 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.76 Bn | 114.52 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.90 Bn | 61.15 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.83 Bn | 62.83 Bn | - |
| 8 | Argenx Se | 55.77 Bn | 50.59 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.45 Bn | 37.45 Bn | - |
| 10 | Longeveron | 15.19 Bn | 15.18 Bn | 264,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 39,000.00 |
| Dec 31, 2025 | 52,000.00 |
| Sep 30, 2025 | 89,000.00 |
| Jun 30, 2025 | 369,000.00 |
| Mar 31, 2025 | 170,000.00 |
| Dec 31, 2024 | 200,000.00 |
| Sep 30, 2024 | 230,000.00 |
| Jun 30, 2024 | 87,000.00 |
| Mar 31, 2024 | 32,000.00 |
| Dec 31, 2023 | -581,000.00 |
| Sep 30, 2023 | 55,000.00 |
| Jun 30, 2023 | 80,000.00 |
| Mar 31, 2023 | 69,000.00 |
| Dec 31, 2022 | 1.88 Mn |
| Sep 30, 2022 | -57,000.00 |
| Jun 30, 2022 | -1.40 Mn |
| Mar 31, 2022 | -116,000.00 |
| Dec 31, 2021 | -37,000.00 |
| Sep 30, 2021 | 50,000.00 |
| Jun 30, 2021 | 52,000.00 |